journal article·2024-04Open access

Macrophage CREBZF Orchestrates Inflammatory Response to Potentiate Insulin Resistance and Type 2 Diabetes

Yuxiao Liu, Weitong Su, Zhengshuai Liu, Zhimin Hu, Jiaxin Shen, Zengpeng Zheng, Dong Ding, Wei Huang, Wenjing Li, Genxiang Cai, Shuang Wei, Ni Li, Xia Fang, Hong Li, Jun Qin, Haibing Zhang, Yichuan Xiao, Yan Bi, Aoyuan Cui, Chunxiang Zhang, Yu Li

Advanced Science· Volume 11· Issue 13

Abstract

Abstract Chronic adipose tissue inflammation accompanied by macrophage accumulation and activation is implicated in the pathogenesis of insulin resistance and type 2 diabetes in humans. The transcriptional coregulator CREBZF is a key factor in hepatic metabolism, yet its role in modulating adipose tissue inflammation and type 2 diabetes remains elusive. The present study demonstrates that overnutrition‐induced CREBZF links adipose tissue macrophage (ATM) proinflammatory activation to insulin resistance. CREBZF deficiency in macrophages, not in neutrophils, attenuates macrophage infiltration in adipose, proinflammatory activation, and hyperglycemia in diet‐induced insulin‐resistant mice. The coculture assays show that macrophage CREBZF deficiency improves insulin sensitivity in primary adipocytes and adipose tissue. Mechanistically, CREBZF competitively inhibits the binding of IκBα to p65, resulting in enhanced NF‐κB activity. In addition, bromocriptine is identified as a small molecule inhibitor of CREBZF in macrophages, which suppresses the proinflammatory phenotype and improves metabolic dysfunction. Furthermore, CREBZF is highly expressed in ATM of obese humans and mice, which is positively correlated with proinflammatory genes and insulin resistance in humans. This study identifies a previously unknown role of CREBZF coupling ATM activation to systemic insulin resistance and type 2 diabetes.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Adipokines, Inflammation, and Metabolic Diseases · Immune cells in cancer · Adipose Tissue and Metabolism

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

CAS Key Laboratory of Nutrition Metabolism and Food Safety Shanghai Institute of Nutrition and Health University of Chinese Academy of Sciences Chinese Academy of Sciences Shanghai 200031 China

Department of Endocrinology and Metabolism The Affiliated Hospital of Southwest Medical University Metabolic Vascular Diseases Key Laboratory of Sichuan Province Luzhou Sichuan 646000 China

CAS Key Laboratory of Tissue Microenvironment and Tumor Shanghai Institute of Nutrition and Health University of Chinese Academy of Sciences Chinese Academy of Sciences Shanghai 200031 China

CAS Key Laboratory of Computational Biology Shanghai Institute of Nutrition and Health Chinese Academy of Sciences Shanghai 200031 China

Affiliated Drum Tower Hospital Medical School of Nanjing University Nanjing Jiangsu 210008 China

Metabolic Vascular Disease Key Laboratory of Sichuan Province The Affiliated Hospital of Southwest Medical University Key Laboratory of Medical Electrophysiology Ministry of Education Southwest Medical University Luzhou 646000 China

Funding

National Natural Science Foundation of China · National Key Research and Development Program of China

References (44)

Show source-provided references
1. 10.1016/j.diabres.2021.10911910.1016/j.diabres.2021.109119 ↗
2. 10.1038/nrendo.2015.18910.1038/nrendo.2015.189 ↗
3. 10.1038/nri307110.1038/nri3071 ↗
4. 10.1016/j.cmet.2014.08.01010.1016/j.cmet.2014.08.010 ↗
5. 10.1172/JCI2906910.1172/JCI29069 ↗
6. 10.1093/nar/28.12.244610.1093/nar/28.12.2446 ↗
7. 10.2337/dbi20-000610.2337/dbi20-0006 ↗
8. 10.1002/hep.2992610.1002/hep.29926 ↗
9. 10.1097/HEP.000000000000004210.1097/HEP.0000000000000042 ↗
10. 10.1002/hep.3091910.1002/hep.30919 ↗
11. 10.1038/nri308810.1038/nri3088 ↗
12. 10.1172/JCI2988110.1172/JCI29881 ↗
13. 10.1016/j.immuni.2010.05.00710.1016/j.immuni.2010.05.007 ↗
14. 10.1016/j.cmet.2008.04.00210.1016/j.cmet.2008.04.002 ↗
15. 10.1172/JCI8888310.1172/JCI88883 ↗
16. 10.1016/j.jim.2014.05.00910.1016/j.jim.2014.05.009 ↗
17. 10.1016/j.immuni.2014.06.00810.1016/j.immuni.2014.06.008 ↗
18. 10.1016/j.cmet.2010.12.00810.1016/j.cmet.2010.12.008 ↗
19. 10.1038/s41392-020-00312-610.1038/s41392-020-00312-6 ↗
20. 10.1016/j.cell.2008.01.02010.1016/j.cell.2008.01.020 ↗
21. 10.1172/JCI2889810.1172/JCI28898 ↗
22. 10.1186/s13059-020-1934-610.1186/s13059-020-1934-6 ↗
23. 10.1242/jcs.110.3.36910.1242/jcs.110.3.369 ↗
24. 10.1002/med.261007020610.1002/med.2610070206 ↗
25. 10.1016/j.ajhg.2019.09.00110.1016/j.ajhg.2019.09.001 ↗
26. 10.1038/nm118510.1038/nm1185 ↗
27. 10.1038/nri242310.1038/nri2423 ↗
28. 10.1126/science.106237410.1126/science.1062374 ↗
29. Zhang F. · Proc. Natl. Acad. Sci. U. S. A. · 2021 · 118
30. 10.1016/S1097-2765(03)00490-810.1016/S1097-2765(03)00490-8 ↗
31. 10.1182/blood.V95.1.27710.1182/blood.V95.1.277 ↗
32. 10.1182/blood-2006-03-01158510.1182/blood-2006-03-011585 ↗
33. 10.1038/nri292510.1038/nri2925 ↗
34. 10.1172/JCI5713210.1172/JCI57132 ↗
35. 10.2337/dc11-006410.2337/dc11-0064 ↗
36. 10.1152/ajpendo.00325.201910.1152/ajpendo.00325.2019 ↗
37. Cincotta A. H. · Int. J. Mol. Sci. · 2022 · 23
38. 10.1016/j.expneurol.2011.08.00110.1016/j.expneurol.2011.08.001 ↗
39. 10.1038/nrd427510.1038/nrd4275 ↗
40. 10.2337/dcS15-301510.2337/dcS15-3015 ↗
41. 10.1016/j.cell.2017.12.02510.1016/j.cell.2017.12.025 ↗
42. 10.7326/0003-4819-159-1-201307020-0000310.7326/0003-4819-159-1-201307020-00003 ↗
43. 10.1023/A:100894282896010.1023/A:1008942828960 ↗
44. 10.1016/j.cmet.2020.12.01910.1016/j.cmet.2020.12.019 ↗